Skip to main content
ATHE
NASDAQ Life Sciences

Substantial Holder's Percentage Ownership Drops, Signaling Significant Dilution

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Negative
Importance info
8
Price
$4.5
Mkt Cap
$77.737M
52W Low
$2.66
52W High
$7
Market data snapshot near publication time

summarizeSummary

Alterity Therapeutics' ADR depositary reported a drop in its percentage ownership, implying significant dilution from new share issuance by the company.


check_boxKey Events

  • Substantial Holder's Percentage Ownership Decreased

    The Bank of New York Mellon Corporation's voting power in Alterity Therapeutics Limited decreased from 28.16% to 26.22%.

  • Absolute Share Count Increased for Depositary

    The depositary's absolute shareholding increased from 2,735,828,317 to 2,851,674,748 ordinary shares.

  • Implied Significant Share Dilution

    The increase in absolute shares held by the depositary, coupled with a decrease in its percentage ownership, indicates a substantial increase in Alterity Therapeutics' total outstanding shares, leading to significant dilution for existing shareholders.


auto_awesomeAnalysis

The Bank of New York Mellon Corporation, acting as the depositary for Alterity Therapeutics' ADR program, reported a decrease in its percentage voting power from 28.16% to 26.22%. This occurred despite an increase in the absolute number of shares held by the depositary, indicating a substantial increase in the company's total outstanding shares. This implied dilution can significantly impact per-share metrics and investor sentiment, suggesting the company has raised capital through new share issuance.

At the time of this filing, ATHE was trading at $4.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $77.7M. The 52-week trading range was $2.66 to $7.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ATHE - Latest Insights

ATHE
Apr 27, 2026, 7:25 AM EDT
Source: GlobeNewswire
Importance Score:
8
ATHE
Apr 27, 2026, 6:21 AM EDT
Filing Type: 6-K
Importance Score:
8
ATHE
Apr 27, 2026, 6:21 AM EDT
Filing Type: 6-K
Importance Score:
8
ATHE
Apr 22, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
8
ATHE
Apr 17, 2026, 6:01 AM EDT
Filing Type: 6-K
Importance Score:
7
ATHE
Apr 16, 2026, 6:06 AM EDT
Filing Type: 6-K
Importance Score:
8
ATHE
Apr 15, 2026, 6:02 AM EDT
Filing Type: 6-K
Importance Score:
7
ATHE
Apr 01, 2026, 6:10 AM EDT
Filing Type: 6-K
Importance Score:
8
ATHE
Mar 30, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
8
ATHE
Mar 19, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
9